Skip to content
10-K

Annual Report

MERRIMACK PHARMACEUTICALS INC

0000950170-23-007063

← back to feed
Filed
Mar 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 7, 2023 14.26M sh
Shares Diluted FY 2022 · Dec 31, 2021 13.41M sh
Operating Cash Flow FY 2022 · Dec 31, 2021 −$218K
Cash And Equivalents FY 2022 · Dec 31, 2021 $14.2M
Current Liabilities FY 2022 · Dec 31, 2021 $562K
Total Liabilities FY 2022 · Dec 31, 2021 $562K
Current Assets FY 2022 · Dec 31, 2021 $14.68M
Total Assets FY 2022 · Dec 31, 2021 $14.75M
Eps Diluted FY 2022 · Dec 31, 2021 −$0.18
Eps Basic FY 2022 · Dec 31, 2021 −$0.18
Operating Income FY 2022 · Dec 31, 2021 −$2.47M
Stockholders Equity FY 2022 · Dec 31, 2020 $16.01M